Industry Verticals »

All Categories

Insights »

About TMR »

Organ Preservation Solutions Market

Organ Preservation Solutions Market (Solution Type : Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solutions and Others), Preservation Technique: Hypothermic Perfusion Preservation, Static Cold Storage and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

  • According to Transparency Market Research’s latest report on the global market for the historical period 2017–2018 and forecast period 2019–2027, rise in organ transplantation, aging population, technological advancements, entry of new players, and increase in access to health care are projected to drive the global organ preservation solution market.
  • According to the report, the global market  was valued at US$ 193.4 Mn in 2018 and is projected to expand at a CAGR of 10.5% from 2019 to 2027

Technological Advancements, and Rise in aging global population: Key Drivers

  • Technological advancements is a major driver accelerating the growth of the organ preservation solutions market. Manufacturers constantly strive to introduce technologically advanced preservation solutions to overcome various challenges such as short duration of organ survival prior to transplantation and tissue edema. For instance, persufflation is promising and simple preservation technique which would improve oxygenation which will improve the grafting during preservation and transplantation.
  • Elderly population are likely to suffer from dysfunctioning of various organs such as kidney, liver and pancreas. In most cases, surgeons prefer organ transplantation as surgeries performed to correct the cause of dysfunction are usually not successful. It has been proven that transplanted organs show higher efficiency in functioning when grafted in the elderly with minimal graft rejection. Thus, increasing geriatric patient population throughout the globe would boost the growth of organ preservation solution market in the near future. As per research, in year 2018, 62% of the people received organ transplantation were in  age group of 50 years or older, and 21% of the organ transplants were more than 65 years or older. Also, in the United States, the oldest organ donor was of age 92 years. 
  • The World Health Organization (WHO) has estimated that the global elderly population will reach around 2 billion by 2050; it was around 524 million in 2010. Moreover, the global geriatric population is expected to grow at the fastest rates in developed countries such as Italy, Germany, the U.K., the U.S. and Japan. Brazil, China, Thailand and South Korea are expected to have a large geriatric population in the shortest span of time in the future. Japan, the U.S. and the U.K. are also expected to follow a similar pattern. This increase in geriatric population would support the growth of the market in the future.

Less availability of organ donor likely to Hamper Market

  • The global organ preservation solution market is driven by the organ transplantation or surgeries which is likely to impact the market. Although, less availability go organ donor for kidney, liver, heart and other transplants are negatively impacting the market. People from nations such as Japan, India and Israel are conservative in their thoughts due to religious concerns.
  • The decreasing trend in the number of organ donors is widening the demand and supply gap and may hamper the growth of the market. Shortage of donor organs has led to a shift in preference of surgeons towards increasing use of artificial organs.  Moreover, lack of reimbursement affects demand for organ transplantation in the developing region.

Global Organ preservation solution market: Competitive Landscape

  • This report profiles major players in the global market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.
  • The global market is fragmented, with the presence of a number of international, regional players as well as local players.
  • Various players operating in the global organ preservation solution market are
    • Dr. Franz Köhler Chemie GmbH
    • Bristol-Myers Squibb Company
    • Teva Pharmaceutical Industries Ltd
    • XVIVO Perfusion AB
    • BioLife Solutions, Inc.
    • 21st Century Medicine
    • Bridge to Life Ltd.
    • Accord Healthcare
    • OrganOx Limited,

Key Developments

Key players in the global organ preservation solution market are engaged in reimbursment scenarios, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies of key players are likely to fuel the growth of the global organ preservation solution industry. A few expansion strategies adopted by players operating in the global organ preservation solution market are:

  • In August 2019, XVIVO Perfusion has received European patent approval of Perfadex Plus for cold preservation lung organ. In year 2018, Perfadex plus was launched in principle markets such as U.S. and Europe and thus patent application of Perfadex plus was submitted across all markets. This products likely to save the time and minimizes the mistakes during the preservation preparation and transplantation.
  • In June 2018, XVivo Perfusion Company received USFDA marketing approval in the United States for its product Perfadex Plus introduced for the cold preservation of the lungs. The product was initially launched in European countries. This USFDA approval would enable the U.S. market to utilize this opportunity during lung transplantation. As per research, 40% of the lung transplants are performed in the United States. 
  • In July 2017, Accord Healthcare completed acquisition of Essential pharmaceuticals Custodiol HTK Solution along with which Accord has a right to sell organ preservation solution in Canada & United States.

The report on the global market discussed individual strategies, followed by company profiles of manufacturers of organ preservation solutions. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global organ preservation solution market.

Global Organ Preservation Solutions Market – Segmentation

Solution Type

Viaspan

Lifor

Custodiol HTK

siRNA Transplant Solutions

Renograf

Hypothermosol

Perfadex

HBS Solution

Others

Preservation Technique

Hypothermic Perfusion Preservation

Static Cold Storage

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of organ preservation solution market?

It is expected to reach US$ 506.3 Mn by 2027

What is the anticipated CAGR of the market in the forecast period?

It is projected to expand at a CAGR of 10.5% from 2019 to 2027

What are the key driving factors for the growth of the market?

Organ preservation solution market is driven by rise in organ transplantation, aging population, and technological advancements

Which is the rising prominent segment in the market?

The Custodial HTK segment held major share of the global organ preservation solutions market and the trend is anticipated to continue during the forecast period

Who are the key players in the organ preservation solution industry?

Dr. Franz Köhler Chemie GmbH, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd, XVIVO Perfusion AB, BioLife Solutions, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Organ Preservation Solutions Market 

    4. Market Overview

        4.1. Introduction

            4.1.1. Market Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Organ Preservation Solutions Market  Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Ageing Global Population 

        5.2.  Technological Advancements

        5.3. Increasing Reimbursment Scenario

        5.4. Increase in per capita healthcare expenditure

    6. Global Organ Preservation Solutions Market  Analysis and Forecast, by Solution Type  

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Organ Preservation Solutions Market  Value Forecast, by Solution Type , 2017–2027

            6.2.1. Viaspan

            6.2.2. Custodiol HTK

            6.2.3. Renograf

            6.2.4. Hypothermosol

            6.2.5. Perfadex

            6.2.6. Lifor

            6.2.7. HBS Solution

            6.2.8. siRNA Transplant Solutions

            6.2.9. Others

        6.3. Global Organ Preservation Solutions Market  Attractiveness, by Solution Type 

    7. Global Organ Preservation Solutions Market  Analysis and Forecast, by Preservation Technique

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Organ Preservation Solutions Market  Value Forecast, by Preservation Technique, 2017–2027

            7.2.1. Hypothermic Perfusion Preservation 

            7.2.2. Static Cold Storage

            7.2.3. Others

        7.3. Global Organ Preservation Solutions Market  Attractiveness, by Preservation Technique  

    8. Global Organ Preservation Solutions Market  Analysis and Forecast, by Region

        8.1. Key Findings

        8.2. Global Organ Preservation Solutions Market  Value Forecast, by Region

            8.2.1. North America 

            8.2.2. Europe 

            8.2.3. Asia Pacific 

            8.2.4. Latin America 

            8.2.5. Middle East & Africa 

        8.3. Global  Organ Preservation Solutions Market  Attractiveness, by Region

    9. North America Organ Preservation Solutions Market  Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

        9.2. North America Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Solution Type , 2017–2027

            9.2.1. Viaspan

            9.2.2. Custodiol HTK

            9.2.3. Renograf

            9.2.4. Hypothermosol

            9.2.5. Perfadex

            9.2.6. Lifor

            9.2.7. HBS Solution

            9.2.8. siRNA Transplant Solutions

            9.2.9. Others 

        9.3. North America Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Preservation Technique , 2017–2027

            9.3.1. Hypothermic Perfusion Preservation 

            9.3.2. Static Cold Storage

            9.3.3. Others 

        9.4. North America Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Country, 2017–2027

            9.4.1. U.S.

            9.4.2. Canada

        9.5. North America Organ Preservation Solutions Market  Attractiveness Analysis 

            9.5.1. By Solution Type  

            9.5.2. By Preservation Technique  

            9.5.3. By Country

    10. Europe Organ Preservation Solutions Market  Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Europe Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Solution Type , 2017–2027

            10.2.1. Viaspan

            10.2.2. Custodiol HTK

            10.2.3. Renograf

            10.2.4. Hypothermosol

            10.2.5. Perfadex

            10.2.6. Lifor

            10.2.7. HBS Solution

            10.2.8. siRNA Transplant Solutions

            10.2.9. Others 

        10.3. Europe Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Preservation Technique , 2017–2027

            10.3.1. Hypothermic Perfusion Preservation 

            10.3.2. Static Cold Storage

            10.3.3. Others 

        10.4. Europe Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            10.4.1. Germany

            10.4.2. U.K.

            10.4.3. France

            10.4.4. Spain

            10.4.5. Italy

            10.4.6. Rest of Europe 

        10.5. Europe Organ Preservation Solutions Market  Attractiveness Analysis 

            10.5.1. By Solution Type 

            10.5.2. By Preservation Technique  

            10.5.3. By Country/Sub-region

    11. Asia Pacific Organ Preservation Solutions Market  Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Asia Pacific Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Solution Type , 2017–2027

            11.2.1. Viaspan

            11.2.2. Custodiol HTK

            11.2.3. Renograf

            11.2.4. Hypothermosol

            11.2.5. Perfadex

            11.2.6. Lifor

            11.2.7. HBS Solution

            11.2.8. siRNA Transplant Solutions

            11.2.9. Others 

        11.3. Asia Pacific Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Preservation Technique , 2017–2027

            11.3.1. Hypothermic Perfusion Preservation 

            11.3.2. Static Cold Storage

            11.3.3. Others 

        11.4. Asia Pacific Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            11.4.1. China

            11.4.2. Japan

            11.4.3. India

            11.4.4. Australia & New Zealand

            11.4.5. Rest of Asia Pacific 

        11.5. Asia Pacific Organ Preservation Solutions Market  Attractiveness Analysis 

            11.5.1. By Solution Type 

            11.5.2. By Preservation Technique  

            11.5.3. By Country/Sub-region

    12. Latin America Organ Preservation Solutions Market  Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Latin America Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Solution Type , 2017–2027

            12.2.1. Viaspan

            12.2.2. Custodiol HTK

            12.2.3. Renograf

            12.2.4. Hypothermosol

            12.2.5. Perfadex

            12.2.6. Lifor

            12.2.7. HBS Solution

            12.2.8. siRNA Transplant Solutions

            12.2.9. Others 

        12.3. Latin America Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Preservation Technique , 2017–2027

            12.3.1. Hypothermic Perfusion Preservation 

            12.3.2. Static Cold Storage

            12.3.3. Others 

        12.4. Latin America Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.4.1. Brazil

            12.4.2. Mexico

            12.4.3. Rest of Latin America 

        12.5. Latin America Organ Preservation Solutions Market  Attractiveness Analysis 

            12.5.1. By Solution Type 

            12.5.2. By Preservation Technique s 

            12.5.3. By Country/Sub-region

    13. Middle East & Africa Organ Preservation Solutions Market  Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Middle East & Africa Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Solution Type , 2017–2027

            13.2.1. Viaspan

            13.2.2. Custodiol HTK

            13.2.3. Renograf

            13.2.4. Hypothermosol

            13.2.5. Perfadex

            13.2.6. Lifor

            13.2.7. HBS Solution

            13.2.8. siRNA Transplant Solutions

            13.2.9. Others 

        13.3. Middle East & Africa Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Preservation Technique , 2017–2027

            13.3.1. Hypothermic Perfusion Preservation 

            13.3.2. Static Cold Storage

            13.3.3. Others 

        13.4. Middle East & Africa Organ Preservation Solutions Market  Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.4.1. GCC Countries

            13.4.2. South Africa

            13.4.3. Rest of Middle East & Africa 

        13.5. Middle East & Africa Organ Preservation Solutions Market  Attractiveness Analysis 

            13.5.1. By Solution Type 

            13.5.2. By Preservation Technique  

            13.5.3. By Country/Sub-region

    14. Competition Landscape

        14.1. Market Share Analysis

        14.2. Company Profiles

            14.2.1. Dr. Franz Köhler Chemie GmbH 

                14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.2.1.2. Growth Strategies

                14.2.1.3. SWOT Analysis

            14.2.2. Bristol-Myers Squibb Company 

                14.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.2.2.2. Financial Overview 

                14.2.2.3. Growth Strategies

                14.2.2.4. SWOT Analysis

            14.2.3. Teva Pharmaceutical Industries Ltd 

                14.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.2.3.2. Financial Overview 

                14.2.3.3. Growth Strategies

                14.2.3.4. SWOT Analysis

            14.2.4. XVIVO Perfusion AB 

                14.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.2.4.2. Growth Strategies

                14.2.4.3. SWOT Analysis

            14.2.5. BioLife Solutions, Inc.

                14.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.2.5.2. Growth Strategies

                14.2.5.3. SWOT Analysis

            14.2.6. 21st Century Medicine 

                14.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.2.6.2. Growth Strategies

                14.2.6.3. SWOT Analysis

            14.2.7. Bridge to Life Ltd

                14.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.2.7.2. Growth Strategies

                14.2.7.3. SWOT Analysis

            14.2.8. Accord Healthcare

                14.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.2.8.2. Growth Strategies

                14.2.8.3. SWOT Analysis

            14.2.9. OrganOx Limited

                14.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                14.2.9.2. Growth Strategies

                14.2.9.3. SWOT Analysis

    List of Tables

    Table 01: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Solution Type, 2017–2027

    Table 02: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Preservation Technique, 2017–2027

    Table 03: Global Plaque Modification Devices Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 04: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Solution Type, 2017–2027

    Table 05: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Preservation Technique, 2017–2027

    Table 06: North America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 07: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Solution Type, 2017–2027

    Table 08: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Preservation Technique, 2017–2027

    Table 09: Europe Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 10: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Solution Type, 2017–2027

    Table 11: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Preservation Technique, 2017–2027

    Table 12: Asia Pacific Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 13: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Solution Type, 2017–2027

    Table 14: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Preservation Technique, 2017–2027

    Table 15: Latin America Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 16: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Solution Type, 2017–2027

    Table 17: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Preservation Technique, 2017–2027

    Table 18: Middle East & Africa Plaque Modification Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    List of Figures

    Figure 01 : Global Organ Preservation Solutions Market Snapshot

    Figure 02: Global Organ Preservation Solutions Market Value (US$ Mn) and Distribution, by Region, 2018 and 2027

    Figure 03: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast, 2017?2027

    Figure 04: Global Organ Preservation Solutions Market Value Share, by Solution Type , 2018

    Figure 05: Global Organ Preservation Solutions Market Value Share, by Preservation Technique   2018

    Figure 06: Global Organ Preservation Solutions Market Value Share, by Region, 2018

    Figure 07: Global Organ Preservation Solutions Market Value Share Analysis, by Solution Type , 2018 and 2027

    Figure 08: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Viaspan, 2017–2027

    Figure 09: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Custodiol HTK, 2017–2027

    Figure 10: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Renograf, 2017–2027

    Figure 11: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hypothermosol, 2017–2027

    Figure 12: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Perfadex, 2017–2027

    Figure 13: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Lifor, 2017–2027

    Figure 14: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by HBS Solution, 2017–2027

    Figure 15: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by siRNA Transplant Solutions, 2017–2027

    Figure 16: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

    Figure 17: Global Organ Preservation Solutions Market Attractiveness Analysis , by Solution Type , 2019–2027

    Figure 18: Global Organ Preservation Solutions Market Value Share Analysis, by Preservation Technique   2018 and 2027

    Figure 19: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hypothermic Perfusion Preservation, 2017–2027

    Figure 20: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Static Cold Storage, 2017–2027

    Figure 21: Global Organ Preservation Solutions Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2017–2027

    Figure 22: Global Organ Preservation Solutions Market Attractiveness Analysis , by Preservation Technique   2019–2027

    Figure 23: Global Organ Preservation Solutions Market Snapshot, by Country/Sub-region

    Figure 24: Global Organ Preservation Solutions Market Value Share Analysis, by Region 2018 and 2027

    Figure 25: Global Organ Preservation Solutions Market Attractiveness Analysis , by Region, 2019–2027

    Figure 26: North America Organ Preservation Solutions Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 27: North America Organ Preservation Solutions Market Value Share (%), by Solution Type , 2018 and 2027

    Figure 28: North America Organ Preservation Solutions Market Attractiveness Analysis , by Solution Type , 2019–2027

    Figure 29: North America Organ Preservation Solutions Market Value Share (%), by Preservation Technique   2018 and 2027

    Figure 30: North America Organ Preservation Solutions Market Attractiveness Analysis , by Preservation Technique   2019–2027

    Figure 31: North America Organ Preservation Solutions Market Value Share (%), by Country/ Sub-region, 2018 and 2027

    Figure 32: North America Organ Preservation Solutions Market Attractiveness Analysis , by Country/ Sub-region, 2019–2027

    Figure 33: Europe Organ Preservation Solutions Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 34: Europe Organ Preservation Solutions Market Value Share (%), by Solution Type , 2018 and 2027

    Figure 35: Europe Organ Preservation Solutions Market Attractiveness Analysis , by Solution Type , 2019–2027

    Figure 36: Europe Organ Preservation Solutions Market Value Share (%), by Preservation Technique   2018 and 2027

    Figure 37: Europe Organ Preservation Solutions Market Attractiveness Analysis , by Preservation Technique   2019–2027

    Figure 38: Europe Organ Preservation Solutions Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 39: Europe Organ Preservation Solutions Market Attractiveness Analysis , by Country/Sub-region, 2019–2027

    Figure 40: Asia Pacific Organ Preservation Solutions Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 41: Asia Pacific Organ Preservation Solutions Market Value Share (%), by Solution Type , 2018 and 2027

    Figure 42: Asia Pacific Organ Preservation Solutions Market Attractiveness Analysis , by Solution Type , 2019–2027

    Figure 43: Asia Pacific Organ Preservation Solutions Market Value Share (%), by Preservation Technique   2018 and 2027

    Figure 54: Asia Pacific Organ Preservation Solutions Market Attractiveness Analysis , by Preservation Technique   2019–2027

    Figure 55: Asia Pacific Organ Preservation Solutions Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 56: Asia Pacific Organ Preservation Solutions Market Attractiveness Analysis , by Country/Sub-region, 2019–2027

    Figure 57: Latin America Organ Preservation Solutions Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 58: Latin America Organ Preservation Solutions Market Value Share (%), by Solution Type , 2018 and 2027

    Figure 59: Latin America Organ Preservation Solutions Market Attractiveness Analysis , by Solution Type , 2019–2027

    Figure 60: Latin America Organ Preservation Solutions Market Value Share (%), by Preservation Technique   2018 and 2027

    Figure 61: Latin America Organ Preservation Solutions Market Attractiveness Analysis , by Preservation Technique   2019–2027

    Figure 62: Latin America Organ Preservation Solutions Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 63: Latin America Organ Preservation Solutions Market Attractiveness Analysis , by Country/Sub-region, 2019–2027

    Figure 64: Middle East & Africa Organ Preservation Solutions Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 65 : Middle East & Africa Organ Preservation Solutions Market Value Share (%), by Solution Type , 2018 and 2027

    Figure 66: Middle East & Africa Organ Preservation Solutions Market Attractiveness Analysis , by Solution Type , 2019–2027

    Figure 67 : Middle East & Africa Organ Preservation Solutions Market Value Share (%), by Preservation Technique   2018 and 2027

    Figure 68: Middle East & Africa Organ Preservation Solutions Market Attractiveness Analysis , by Preservation Technique   2019–2027

    Figure 69: Middle East & Africa Organ Preservation Solutions Market Value Share (%), by Country/Sub-region, 2018 and 2027

    Figure 70: Middle East & Africa Organ Preservation Solutions Market Attractiveness Analysis , by Country/Sub-region, 2019–2027

Copyright © Transparency Market Research, Inc. All Rights reserved

Organ Preservation Solutions Market

Schedule a Call